{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:26:41Z","timestamp":1791545201791,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009527","name":"Statens Serum Institut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008634","name":"University of Texas at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cmi.2024.10.010","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:49:33Z","timestamp":1729277373000},"page":"108-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Candida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant?"],"prefix":"10.1016","volume":"31","author":[{"given":"Maiken Cavling","family":"Arendrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Wiederhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.10.010_bib1","volume":"vol. 184","author":"Theut","year":"2022"},{"key":"10.1016\/j.cmi.2024.10.010_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.14.2300161","article-title":"In\u00a0vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022","volume":"28","author":"Codda","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2024.10.010_bib3","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3389\/fmicb.2019.02788","article-title":"Review on antifungal resistance mechanisms in the emerging pathogen Candida auris","volume":"10","author":"Chaabane","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2024.10.010_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.010_bib26","doi-asserted-by":"crossref","first-page":"e02438","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin in vitro activity against contemporary Nordic clinical Candida isolates and Candida auris determined by the EUCAST reference method","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib5","doi-asserted-by":"crossref","first-page":"1083.e1","DOI":"10.1016\/j.cmi.2023.04.025","article-title":"Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs","volume":"29","author":"Ben Abid","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.10.010_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/myc.13390","article-title":"Laboratory-based surveillance of Candida auris in Colombia, 2016-2020","volume":"65","author":"Escand\u00f3n","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.10.010_bib7","first-page":"430","article-title":"The mortality attributable to Candidemia in C. auris is higher than that in other Candida species: myth or reality?","volume":"9","author":"Alvarez-Moreno","year":"2023","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.cmi.2024.10.010_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106558","article-title":"Head-to-head comparison of CLSI, EUCAST, Etest and VITEK\u00ae2 results for Candida auris susceptibility testing","volume":"59","author":"Ceballos-Garzon","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2024.10.010_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04431-22","article-title":"Overestimation of amphotericin B resistance in Candida auris with sensititre YeastOne antifungal susceptibility testing: a need for adjustment for correct interpretation","volume":"11","author":"Siopi","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2024.10.010_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","volume":"53","author":"Kathuria","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.10.010_bib11","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.cmi.2016.01.017","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.10.010_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkac373","article-title":"Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin","volume":"78","author":"Arendrup","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib13","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeast","year":"2017"},{"key":"10.1016\/j.cmi.2024.10.010_bib14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/jac\/dkab088","article-title":"ISO standard 20776-1 or serial 2-fold dilution for antifungal susceptibility plate preparation: that is the question","volume":"76","author":"Arendrup","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib15","first-page":"141","article-title":"A\u00a0pragmatic approach to susceptibility classification of yeasts without EUCAST clinical breakpoints","volume":"8","author":"Astvad","year":"2022","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"Suppl.\u00a0l_3","key":"10.1016\/j.cmi.2024.10.010_bib17","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.010_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in\u00a0vivo in Candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib19","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1128\/AAC.01145-12","article-title":"Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2","volume":"56","author":"Hull","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib20","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1128\/AAC.00423-08","article-title":"A\u00a0nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata","volume":"52","author":"Vandeputte","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib21","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib22","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A\u00a0clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14 alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.10.010_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03333-20","article-title":"Genome-wide analysis of experimentally evolved candida auris reveals multiple novel mechanisms of multidrug resistance","volume":"12","author":"Carolus","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2024.10.010_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciy411","article-title":"Molecular epidemiology of candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance","volume":"68","author":"Escand\u00f3n","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.010_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15698\/mic2016.07.512","article-title":"Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1","volume":"3","author":"Laprade","year":"2016","journal-title":"Microb Cell"},{"key":"10.1016\/j.cmi.2024.10.010_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris pan-drug-resistant to four classes of antifungal agents","volume":"66","author":"Jacobs","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:53:49Z","timestamp":1738450429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1198743X24004920"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.10.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant?","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}